Patient must have a left ventricular ejection fraction >= institutional lower limit of normal (LLN) by echocardiogram (ECHO) or multigated acquisition (MUGA) within 28 days prior to registration
97.0
Left ventricular ejection fraction >= institutional lower limit of normal (LLN) by echocardiogram (ECHO)
40.0
Left ventricular ejection fraction >= institutional lower limit of normal (LLN) by echocardiogram (ECHO), within 2 weeks of the first dose of study treatment
18.0
Left ventricular ejection fraction >= institutional lower limit of normal (LLN) by echocardiogram (ECHO)
68.0
Left ventricular ejection fraction (LVEF) >= institutional lower limit of normal (LLN) by echocardiogram (ECHO) or multigated acquisition scan (MUGA)
68.0
Left ventricular >= institutional lower limit of normal (LLN) by echocardiogram (ECHO) ejection fraction
32.0
Left ventricular ejection fraction >= institutional lower limit of normal (LLN) by echocardiogram (ECHO)
18.0
Left ventricular ejection fraction (LVEF) >= institutional lower limit of normal (LLN) by echocardiogram (ECHO) or multigated acquisition scan (MUGA) within 30 days of day 1 of study
27.0
